Back
Organon & Co. 10K Form
Sell
46
OGN
Organon & Co.
Last Price:
$6.36
Seasonality Move:
-8.03%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OGN News And Ratings
See the #1 stock for the next 7 days that we like better than OGN
OGN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.2B |
|---|---|
| Cash Flow: | $200M |
| Price / Cash Flow: | 3.38 |
| Annual Sales: | $2.89 |
| Price / Book: | 2.28 |
Profitability
| EPS (TTM): | 0.71660 |
|---|---|
| Net Income (TTM): | $187M |
| Gross Margin: | $3.4B |
| Return on Equity: | 27.46% |
| Return on Assets: | 1.41% |
Organon & Co. Earnings Forecast
Key Organon & Co. Financial Ratios
-
The Gross Profit Margin over the past 9 years for OGN is 54.09%.
-
The Selling, General & Administrative Expenses for OGN have been equal to 27.69% of Gross Profit Margin.
-
The Research & Development expenses have been 5.89% of Revenue.
-
The Interest Expense is 274.87% of Operating Income.
-
The Net Earning history of OGN is 3.01% of Total Revenues.
-
Per Share Earnings over the last 9 years have been positive in 3 years.
Organon & Co. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OGN |
| Website: | organon.com |
Debt
| Debt-to-Equity Ratio: | 11.7 |
|---|---|
| Current Ratio: | 1.82 |
| Quick Ratio: | 0.8 |
Price-to-Earnings
| Trailing P/E Ratio: | 9.19 |
|---|---|
| Forward P/E Ratio: | 1.77 |
OGN Technical Analysis vs Fundamental Analysis
Sell
46
Organon & Co. (OGN)
is a Sell
Is Organon & Co. a Buy or a Sell?
-
Organon & Co. stock is rated a SellThe current Organon & Co. [OGN] share price is $6.36. The Score for OGN is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.